Bradley J. Bolzon Ph.D., Director at CRISPR Therapeutics AG (CRSP), sold 18,100 shares at $128.65 ($2.3M) on 2021-06-11, disclosed to the SEC on 2021-06-15.
Open-market sale of $2.3M CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.62 | 5,427 | $682K | 29.8% |
| 2 | $125.62 | 5,427 | $682K | 29.8% |
| 3 | $126.59 | 1,918 | $243K | 10.6% |
| 4 | $126.59 | 1,918 | $243K | 10.6% |
| 5 | $127.88 | 800 | $102K | 4.5% |
| 6 | $128.65 | 1,100 |
| $142K |
| 6.2% |
| 7 | $129.45 | 755 | $98K | 4.3% |
| 8 | $129.45 | 755 | $98K | 4.3% |
| Total | $126.43 avg | 18,100 | $2.3M | 100% |
| Filing → |
| CRSP | SELL | 2021-06-30 | $14.1M | — | Filing → |
| CRSP | SELL | 2021-06-30 | $9.2M | — | Filing → |
| CRSP | SELL | 2021-03-24 | $8.0M | — | Filing → |